Verproside, a catalpol derivative iridoid glycoside isolated from Pseudolysimachion rotundum var. subintegrum, is a biologically active compound with anti-inflammatory, antinociceptic, antioxidant, and anti-asthmatic properties. Twenty-one metabolites were identified in bile and urine samples obtained after intravenous administration of verproside in rats using liquid chromatography-quadrupole Orbitrap mass spectrometry. Verproside was metabolized by O-methylation, glucuronidation, sulfation, and hydrolysis to verproside glucuronides (M1 and M2), verproside sulfates (M3 and M4), picroside II (M5), M5 glucuronide (M7), M5 sulfate (M9), isovanilloylcatalpol (M6), M6 glucuronide (M8), M6 sulfate (M10), 3,4-dihydroxybenzoic acid (M11), M11 glucuronide (M12), M11 sulfates (M13 and M14), 3-methyoxy-4-hydroxybenzoic acid (M15), M15 glucuronides (M17 and M18), M15 sulfate (M20), 3-hydroxy-4-methoxybenzoic acid (M16), M16 glucuronide (M19), and M16 sulfate (M21). Incubation of verproside with rat hepatocytes resulted in thirteen metabolites (M1–M11, M13, and M14). Verproside sulfate, M4 was a major metabolite in rat hepatocytes. After intravenous administration of verproside, the drug was recovered in bile (0.77% of dose) and urine (4.48% of dose), and O-methylation of verproside to picroside II (M5) and isovanilloylcatalpol (M6) followed by glucuronidation and sulfation was identified as major metabolic pathways compared to glucuronidation and sulfation of verproside in rats.
References
[1]
Recio, M.C.; Giner, R.M.; Manez, S.; Rios, J.L. Structural considerations on the iridoids as anti-inflammatory agents. Planta Med. 1994, 60, 232–234, doi:10.1055/s-2006-959465.
[2]
Kupeli, E.; Harput, U.S.; Varel, M.; Yesilada, E.; Saracoglu, I. Bioassay-guided isolation of iridoid glucosides with antinociceptive and anti-inflammatory activities from Veronica anagallis-aquatica L. J. Ethnopharmacol. 2005, 102, 170–176, doi:10.1016/j.jep.2005.05.042.
[3]
Dinda, B.; Debnath, S.; Harigaya, Y. Naturally occurring iridoids. A review, Part 1. Chem. Pharm. Bull. 2007, 55, 159–222, doi:10.1248/cpb.55.159. 17268091
[4]
Kwak, J.H.; Kim, H.J.; Lee, K.H.; Kang, S.C.; Zee, O.P. Antioxidative iridoid glycosides and phenolic compounds from Veronica peregrina. Arch. Pharm. Res. 2009, 32, 207–213, doi:10.1007/s12272-009-1137-x.
[5]
Saracoglu, I.; Oztunca, F.H.; Nagatsu, A.; Harput, U.S. Iridoid content and biological activities of Veronica cuneifolia subsp. cuneifolia and V. cymbalaria. Pharm. Biol. 2011, 49, 1150–1157, doi:10.3109/13880209.2011.575790.
[6]
Oh, S.R.; Lee, M.Y.; Ahn, K.S.; Park, B.Y.; Kwon, O.K.; Joung, H.; Lee, J.; Kim, D.Y.; Lee, S.; Kim, J.H.; et al. Suppressive effect of verproside isolated from Pseudolysimachion longifolium on airway inflammation in a mouse model of allergic asthma. Int. Immunopharmacol. 2006, 6, 978–986, doi:10.1016/j.intimp.2006.01.010.
[7]
Park, E.J.; Oh, S.R.; Lee, H.K.; Lee, H.S. Liquid chromatography-mass spectrometry for the simultaneous determination of the catalpol-related iridoid glucosides, verproside, isovanilloylcatalpol, catalposide and 6-O-veratroyl catalpol in rat plasma. Biomed. Chromatogr. 2009, 23, 980–986, doi:10.1002/bmc.1211.
[8]
Park, E.J.; Lee, H.S.; Oh, S.R.; Lee, H.K.; Lee, H.S. Pharmacokinetics of verproside after intravenous and oral administration in rats. Arch. Pharm. Res. 2009, 32, 559–564, doi:10.1007/s12272-009-1412-x.
[9]
Hong, J.L.; Qin, X.Y.; Shu, P.; Wu, G.; Wang, Q.; Qin, M.J. Analysis of catalpol derivatives by characteristic neutral losses using liquid chromatography combined with electrospray ionization multistage and time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 2010, 24, 2680–2686, doi:10.1002/rcm.4676.
[10]
Li, T.; Yu, Q.; Han, D.; Zhao, Y.; Zhao, D.; Ji, H.; Chen, X.; Li, N.; Qiu, Z.; Zheng, Y. Elucidation of the Structures of Metabolites of Picroside II in Rat Bile by LC–ESI–IT–MS. Chromatographia 2011, 73, 1111–1120, doi:10.1007/s10337-011-2002-x.
